tiprankstipranks
Trending News
More News >
Biocryst Pharmaceuticals (BCRX)
NASDAQ:BCRX
US Market

BioCryst (BCRX) Income Statement

Compare
2,690 Followers

BioCryst Income Statement

Last quarter (Q4 2025), BioCryst's total revenue was $406.56M, an increase of 209.09% from the same quarter last year. In Q4, BioCryst's net income was $245.84M. See BioCryst’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 874.84M$ 450.71M$ 331.41M$ 270.83M$ 157.17M
Gross Profit
$ 855.76M$ 438.23M$ 326.75M$ 264.23M$ 149.91M
Operating Expenses
$ 514.77M$ 440.77M$ 430.46M$ 412.67M$ 327.63M
Depreciation and Amortization
$ 1.39M$ 1.25M$ 1.66M$ 1.44M$ 777.00K
EBITDA
$ 347.65M$ 12.81M$ -116.33M$ -143.85M$ -121.74M
Operating Income
$ 340.99M$ -2.54M$ -103.71M$ -148.44M$ -177.72M
Other Income/Expenses
$ -73.60M$ -84.41M$ -122.52M$ -95.95M$ -4.09M
Pretax Income
$ 267.39M$ -86.95M$ -226.23M$ -244.38M$ -181.81M
Net Income
$ 263.86M$ -88.88M$ -226.54M$ -247.12M$ -184.06M
Per Share Metrics
Basic EPS
$ 1.26$ -0.43$ -1.18$ -1.33$ -1.03
Diluted EPS
$ 1.21$ -0.43$ -1.18$ -1.33$ -1.03
Weighted Average Shares Outstanding
209.89M 206.70M 192.20M 185.91M 179.12M
Weighted Average Shares Outstanding (Diluted)
218.58M 206.70M 192.20M 185.91M 179.12M
Currency in USD

BioCryst Earnings and Revenue History